BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24280457)

  • 1. Clinical updates in blood and marrow transplantation in multiple myeloma.
    Faiman B; Miceli T; Noonan K; Lilleby K
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():33-41. PubMed ID: 24280457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice.
    Miceli T; Lilleby K; Noonan K; Kurtin S; Faiman B; Mangan PA
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():13-24. PubMed ID: 24280455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing landscape of multiple myeloma: implications for oncology nurses.
    Kurtin S; Faiman B
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():7-11. PubMed ID: 24280454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
    Koniarczyk HL; Ferraro C; Miceli T
    Semin Oncol Nurs; 2017 Aug; 33(3):265-278. PubMed ID: 28729120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematopoietic stem cell transplantation: current status.
    Kumar L
    Natl Med J India; 2007; 20(3):128-37. PubMed ID: 17867617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
    Shimoni A; Smith TL; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno NT; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 Apr; 27(8):821-8. PubMed ID: 11477439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
    Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
    Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of stem cell transplantation.
    Harousseau JL
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.
    Mangan PA; Gleason CL; Miceli T
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():43-7. PubMed ID: 24280458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stem cell transplantation in multiple myeloma].
    Fukuda S; Sunami K; Sezaki T
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1407-14. PubMed ID: 10500527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.
    Vesole DH; Simic A; Lazarus HM
    Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced.
    van Dorp S; Meijer E; van de Donk NW; Dekker AW; Nieuwenhuis K; Minnema MC; Petersen E; Schutgens R; Verdonck LF; Lokhorst HM
    Neth J Med; 2007 May; 65(5):178-84. PubMed ID: 17519513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive treatment strategies in multiple myeloma.
    Kovacsovics TJ; Delaly A
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):49-60. PubMed ID: 9122746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.